ReviewDiscover oncology2025
Progress in the antitumor molecular mechanisms of Isorhamnetin.
Anyang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ReviewDiscover oncology2025
Anyang Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.